My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism.

    Qiao L, Zou C, van der Westhuyzen DR, Shao J.

    Diabetes. 2008 Jul;57(7):1824-33. Epub 2008 Mar 28.PMID: 18375436 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.

    Schaap FG, Rensen PC, Voshol PJ, Vrins C, van der Vliet HN, Chamuleau RA, Havekes LM, Groen AK, van Dijk KW.

    J Biol Chem. 2004 Jul 2;279(27):27941-7. Epub 2004 Apr 16.PMID: 15090553 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice.

    Tsukamoto K, Maugeais C, Glick JM, Rader DJ.

    J Lipid Res. 2000 Feb;41(2):253-9.PMID: 10681409 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.

    Merkel M, Loeffler B, Kluger M, Fabig N, Geppert G, Pennacchio LA, Laatsch A, Heeren J.

    J Biol Chem. 2005 Jun 3;280(22):21553-60. Epub 2005 Mar 17.PMID: 15774484 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity. Possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency.

    Yagyu H, Lutz EP, Kako Y, Marks S, Hu Y, Choi SY, Bensadoun A, Goldberg IJ.

    J Biol Chem. 2002 Mar 22;277(12):10037-43. Epub 2002 Jan 14.PMID: 11790777 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.

    Aalto-Setälä K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg HN, Breslow JL.

    J Clin Invest. 1992 Nov;90(5):1889-900.PMID: 1430212 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cells.

    Liu G, Excoffon KJ, Benoit P, Ginzinger DG, Miao L, Ehrenborg E, Duverger N, Denefle PP, Hayden MR, Lewis ME.

    Hum Gene Ther. 1997 Jan 20;8(2):205-14.PMID: 9017424 [PubMed - indexed for MEDLINE]Related articles

    8.

    A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice.

    Ando Y, Shimizugawa T, Takeshita S, Ono M, Shimamura M, Koishi R, Furukawa H.

    J Lipid Res. 2003 Jun;44(6):1216-23. Epub 2003 Apr 1.PMID: 12671033 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B.

    Tietge UJ, Bakillah A, Maugeais C, Tsukamoto K, Hussain M, Rader DJ.

    J Lipid Res. 1999 Nov;40(11):2134-9.PMID: 10553017 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.

    Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L.

    Hum Gene Ther. 1997 Nov 1;8(16):1921-33.PMID: 9382958 [PubMed - indexed for MEDLINE]Related articles

    11.

    Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.

    Li J, Li H, Wen YB, Li XW.

    Nephron Physiol. 2008;110(1):p1-10. Epub 2008 Aug 13.PMID: 18698144 [PubMed - indexed for MEDLINE]Related articles

    12.

    The VLDL receptor plays a major role in chylomicron metabolism by enhancing LPL-mediated triglyceride hydrolysis.

    Goudriaan JR, Espirito Santo SM, Voshol PJ, Teusink B, van Dijk KW, van Vlijmen BJ, Romijn JA, Havekes LM, Rensen PC.

    J Lipid Res. 2004 Aug;45(8):1475-81. Epub 2004 May 16.PMID: 15145981 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.

    St-Amand J, Moorjanit S, Lupien PJ, Prud'homme D, Després JP.

    Metabolism. 1996 Feb;45(2):261-7.PMID: 8596500 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle.

    Haemmerle G, Zimmermann R, Strauss JG, Kratky D, Riederer M, Knipping G, Zechner R.

    J Biol Chem. 2002 Apr 12;277(15):12946-52. Epub 2002 Jan 23.PMID: 11809748 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and high-density lipoprotein-cholesterol levels.

    Levak-Frank S, Hofmann W, Weinstock PH, Radner H, Sattler W, Breslow JL, Zechner R.

    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3165-70.PMID: 10077655 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?

    Pruneta V, Autran D, Ponsin G, Marcais C, Duvillard L, Verges B, Berthezene F, Moulin P.

    J Clin Endocrinol Metab. 2001 Feb;86(2):797-803.PMID: 11158049 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer.

    Liu G, Excoffon KJ, Wilson JE, McManus BM, Miao L, Benoit P, Duverger N, Branellec D, Denefle P, Hayden MR, Lewis ME.

    Clin Invest Med. 1998 Aug-Oct;21(4-5):172-85.PMID: 9800066 [PubMed - indexed for MEDLINE]Related articles

    18.

    In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.

    Jong MC, Dahlmans VE, van Gorp PJ, van Dijk KW, Breuer ML, Hofker MH, Havekes LM.

    J Clin Invest. 1996 Nov 15;98(10):2259-67.PMID: 8941642 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice.

    Tacken PJ, Teusink B, Jong MC, Harats D, Havekes LM, van Dijk KW, Hofker MH.

    J Lipid Res. 2000 Dec;41(12):2055-62.PMID: 11108739 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis.

    Kako Y, Huang LS, Yang J, Katopodis T, Ramakrishnan R, Goldberg IJ.

    J Lipid Res. 1999 Dec;40(12):2185-94.PMID: 10588944 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity